AMILI
Singapore
About AMILI
AMILI develops diagnostic tests, predictive algorithms, and microbiome-modifying interventions. They also offer probiotics and diagnostic tests based on their own microbiome database. They also provide faecal microbiota transplants to aid in the treatment of bacterial infections.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.5M
- Last round: Series Unknown (May 2023)
- Website: amili.asia
- Phone: +65 6977 7199
Industries & Categories
Fitness, Health Care, Wellness
Social Profiles
Canonical: https://fsome.com/organization/amili-47047 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.